LAS VEGAS, Nov 01, 2005 (BUSINESS WIRE) -- NanoSignal Corp., a fully reporting OTC PINK SHEET Company (NNOS), announced today that it has entered into an international franchising agreement with FranTech International Licensing of Ventura, Calif.
Under the agreement, FranTech International Licensing will promote and license franchises in more than 220 countries. The franchisee will have the right to market NanoSignal Corp. products including its Slices(TM) technology. "This represents the next step in the development of the company," said NanoSignal President Kelly O. Slade. "FranTech is the leader in international franchising opportunities," added Slade.
"Over the next few months, NanoSignal will be establishing relationships with several other medical technology companies in joint marketing programs. This will further enhance NanoSignal's position in the market and will provide revenue streams for the company," said Dr. Rupert Perrin, chairman of the board.
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements can be identified by the lead-in "Looking Forward." These statements are not guarantees of future performance and involve significant risks and uncertainties. Actual results may vary materially from those claims made in the forward-looking statements.
SOURCE: NanoSignal Corp.
